Localization of O-glycosylation sites on glycopeptide fragments from lactation-associated MUC1. All putative sites within the tandem repeat are glycosylation targets in vivo.
about
Synthetic self-adjuvanting glycopeptide cancer vaccinesCloning of a human UDP-N-acetyl-alpha-D-Galactosamine:polypeptide N-acetylgalactosaminyltransferase that complements other GalNAc-transferases in complete O-glycosylation of the MUC1 tandem repeatExpression of polypeptide GalNAc-transferases in stratified epithelia and squamous cell carcinomas: immunohistological evaluation using monoclonal antibodies to three members of the GalNAc-transferase familyDatabase analysis of O-glycosylation sites in proteins.Cloning and characterization of a ninth member of the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase family, ppGaNTase-T9Deglycosylation of glycoproteins with trifluoromethanesulphonic acid: elucidation of molecular structure and function.Dynamic epigenetic regulation of initial O-glycosylation by UDP-N-Acetylgalactosamine:Peptide N-acetylgalactosaminyltransferases. site-specific glycosylation of MUC1 repeat peptide influences the substrate qualities at adjacent or distant Ser/Thr poRecombinant MUC1 probe authentically reflects cell-specific O-glycosylation profiles of endogenous breast cancer mucin. High density and prevalent core 2-based glycosylation.N-Glycosylation of the MUC1 mucin in epithelial cells and secretions.Polypeptide GalNAc-transferases, ST6GalNAc-transferase I, and ST3Gal-transferase I expression in gastric carcinoma cell lines.Mass spectrometry based glycoproteomics--from a proteomics perspectiveToward optimized carbohydrate-based anticancer vaccines: epitope clustering, carrier structure, and adjuvant all influence antibody responses to Lewis(y) conjugates in miceElucidating heterogeneity of IgA1 hinge-region O-glycosylation by use of MALDI-TOF/TOF mass spectrometry: role of cysteine alkylation during sample processing.Core-glycosylated mucin-like repeats from MUC1 are an apical targeting signalCharacterization of cancer associated mucin type O-glycans using the exchange sialylation properties of mammalian sialyltransferase ST3Gal-II.Site-specific analysis of von Willebrand factor O-glycosylation.An anti-MUC1-antibody-interleukin-2 fusion protein that activates resting NK cells to lysis of MUC1-positive tumour cells.Identification of Novel N-Glycosylation Sites at Noncanonical Protein Consensus Motifs.Identification of O-glycosylated decapeptides within the MUC1 repeat domain as potential MHC class I (A2) binding epitopes.A unified strategy for the synthesis of mucin cores 1-4 saccharides and the assembled multivalent glycopeptides.Regulation of O-glycosylation through Golgi-to-ER relocation of initiation enzymes.The lectin domain of UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-T4 directs its glycopeptide specificities.Identification of substituted sites on MUC5AC mucin motif peptides after enzymatic O-glycosylation combining beta-elimination and fixed-charge derivatization.NMR-based determination of the binding epitope and conformational analysis of MUC-1 glycopeptides and peptides bound to the breast cancer-selective monoclonal antibody SM3.Glycosylation of MUC1 influences the binding of a therapeutic antibody by altering the conformational equilibrium of the antigen.Engineering O-Glycosylation Points in Non-extended Peptides: Implications for the Molecular Recognition of Short Tumor-Associated Glycopeptides
P2860
Q26777837-5E77C47C-BE2D-4B8B-B790-5AC18219AE1EQ28118379-E88733AD-A217-46AE-8958-0000B4EC616DQ28293531-FF7B414F-A440-473B-AD0C-62489AFFF887Q28346313-E32796B6-6730-42C7-A0E4-7CEB6D4CB5C5Q28587735-9EC394F4-ACCF-4119-B3B4-958977894311Q30333497-35D85BAA-1F8B-4455-92F4-53C564C34187Q30667253-6C459FEF-42B2-445A-9453-5802E9E4D70BQ31051680-38804D7E-5731-4860-A9A2-888CC711C8CBQ33238547-9CA089D9-5B65-4BD4-8019-BA226F3DCEF9Q34198013-9A5291CF-F792-434E-84EA-EC01FB2B7291Q34454989-92210289-0686-4990-8FF2-F209401CCEC3Q34719681-763F9C50-58C9-44C9-A841-2C1D42815124Q34869928-37F142EB-F25B-4EAA-A698-D054CDF6668FQ35604269-A3FC3912-918A-42C2-87FE-B120F01C283CQ35874802-438663C5-C24C-4C9C-8122-6BA97DD3555CQ35897602-400EF2F5-A242-4F99-BB4D-40F4493D0B0FQ36648430-4058B1EC-9C7B-4E07-B04C-B4F4086AC355Q37401444-1807840E-5E43-45B7-98B2-FE64C4558139Q37459645-5113E95B-E8D2-47BE-AC15-641BEE9170E9Q39301160-A36C81EE-555C-444F-AF68-C89CC3AD1BECQ39700918-509A31E1-718A-46BC-84CF-5AF52A26F83CQ40855480-ADF667B6-AB73-4E21-9F3E-A4FCBF8AF6A7Q43831385-94F9F8E7-8427-49AE-93DB-06AA487392CAQ43902828-52906EBA-EC50-4236-918E-64BB1286361CQ46174844-DEAB0C9A-2C36-4DE6-9B5F-F0A4E209DFB0Q57515385-A710DFD6-04A8-4BD0-AFAB-92B82FABCC57
P2860
Localization of O-glycosylation sites on glycopeptide fragments from lactation-associated MUC1. All putative sites within the tandem repeat are glycosylation targets in vivo.
description
1997 nî lūn-bûn
@nan
1997 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Localization of O-glycosylatio ...... glycosylation targets in vivo.
@ast
Localization of O-glycosylatio ...... glycosylation targets in vivo.
@en
Localization of O-glycosylatio ...... glycosylation targets in vivo.
@nl
type
label
Localization of O-glycosylatio ...... glycosylation targets in vivo.
@ast
Localization of O-glycosylatio ...... glycosylation targets in vivo.
@en
Localization of O-glycosylatio ...... glycosylation targets in vivo.
@nl
prefLabel
Localization of O-glycosylatio ...... glycosylation targets in vivo.
@ast
Localization of O-glycosylatio ...... glycosylation targets in vivo.
@en
Localization of O-glycosylatio ...... glycosylation targets in vivo.
@nl
P2093
P2860
P356
P1476
Localization of O-glycosylatio ...... glycosylation targets in vivo.
@en
P2093
P2860
P304
24780-24793
P356
10.1074/JBC.272.40.24780
P407
P577
1997-10-01T00:00:00Z